Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable Outcome

1 Sept 2006

Abstract excerpt

PURPOSE: Identification of molecular characteristics of spontaneously regressing stage IVS and progressing stage IV neuroblastoma to improve discrimination of patients with metastatic disease following favorable and unfavorable clinical courses. EXPERIMENTAL DESIGN: Serial analysis of gene expression profiles were generated from five stage IVS and three stage IV neuroblastoma. Differential expression of candidate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Neuroblastoma Research and Treatments
Share to Neurofibromatosis and Schwannoma Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16951229
DOI: 10.1158/1078-0432.ccr-06-0985

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential Expression of Neuronal Genes Defines Subtypes of Disseminated Neuroblastoma with Favorable and Unfavorable OutcomePMID 16951229Read ↗

Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsetsSemantic proximity Read ↗

Prognostic Significance of Gene Expression Profiles of Metastatic Neuroblastomas Lacking MYCN Gene AmplificationSemantic proximity Read ↗

High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastomaSemantic proximity Read ↗

MYCN‐non‐amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4SSemantic proximity Read ↗

Prognostic Impact of Gene Expression–Based Classification for NeuroblastomaSemantic proximity Read ↗

Identification of DEIN, a novel gene with high expression levels in stage IVS neuroblastoma.Semantic proximity Read ↗

Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastomaSemantic proximity Read ↗

Clinically Relevant Biomarker Discovery in High-Risk Recurrent NeuroblastomaSemantic proximity Read ↗

Prediction of clinical outcome and biological characterization of neuroblastoma by expression profilingSemantic proximity Read ↗

The biologic basis for neuroblastoma heterogeneity and risk stratification.Semantic proximity Read ↗

Expression profiling of favorable and unfavorable neuroblastomasSemantic proximity Read ↗

Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.